| Particulars |
|
|
|
| Company Name
| Fredun Pharmaceuticals Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
5.51 |
B.V. (₹) |
489.40 |
| Sales(₹ Cr.) |
635.47 |
NP (₹ Cr.) |
33.21 |
| NP Var% |
60.00 |
Div% |
7.00 |
| CPS(₹) |
74.60 |
EPS (₹) |
60.20 |
| Traded Value(₹ Lakhs) |
486.18 |
52 Week High |
2,699.00 |
| 52 Week Low |
794.00 |
Price BSE |
2,495.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
1,375.64 |
| P/C Ratio |
33.40 |
P/E Ratio |
41.40 |
| Price Vs.BV |
5.10 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
210.41 |
| NP(₹ Cr.) |
11.07 |
NP Var % |
56.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
388.30 |
| OPM |
0.00 |
NP |
17.69 |
| NP Var% |
59.59 |
EPS |
60.24 |
| PE |
41.42 |
|
|